BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9129128)

  • 1. Inhibition by L-NA, a nitric oxide synthase inhibitor, of naloxone-precipitated withdrawal signs in a mouse model of cholestasis.
    Ghafourifar P; Dehpour AR; Akbarloo N
    Life Sci; 1997; 60(19):PL 265-70. PubMed ID: 9129128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis.
    Dehpour AR; Akbarloo N; Ghafourifar P
    Behav Pharmacol; 1998 Feb; 9(1):77-80. PubMed ID: 9832951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine attenuates naloxone-induced opioid-withdrawal syndrome in cholestatic mice.
    Dehpour AR; Samini M; Arad MA; Namiranian K
    Pharmacol Toxicol; 2001 Sep; 89(3):129-32. PubMed ID: 11589783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice.
    Dambisya YM; Lee TL
    Br J Pharmacol; 1996 Mar; 117(5):914-8. PubMed ID: 8851510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
    Cappendijk SL; de Vries R; Dzoljic MR
    Neurosci Lett; 1993 Nov; 162(1-2):97-100. PubMed ID: 7510058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
    Hall S; Milne B; Jhamandas K
    Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice.
    Nasehi M; Piri M; Abbolhasani K; Zarrindast MR
    Behav Pharmacol; 2013 Jun; 24(3):180-94. PubMed ID: 23604167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems.
    Namiranian K; Samini M; Mehr SE; Gaskari SA; Rastegar H; Homayoun H; Dehpour AR
    Eur J Pharmacol; 2001 Jul; 423(2-3):185-93. PubMed ID: 11448484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats.
    Ebrahimi F; Tavakoli S; Hajrasouliha AR; Shafaroodi H; Sadeghipour H; Riazi K; Borhani AA; Houshmand G; Ahmadi SH; Dehpour AR
    Eur J Pharmacol; 2005 Oct; 523(1-3):93-100. PubMed ID: 16226248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.
    Cao JL; Liu HL; Wang JK; Zeng YM
    Neuropharmacology; 2006 Aug; 51(2):315-26. PubMed ID: 16712881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between brain nitric oxide synthase activity and opiate withdrawal.
    Leza JC; Lizasoain I; Cuéllar B; Moro MA; Lorenzo P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):349-54. PubMed ID: 8692292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal.
    Lewanowitsch T; Irvine RJ
    Eur J Pharmacol; 2002 Jun; 445(1-2):61-7. PubMed ID: 12065195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orphanin FQ/nociceptin inhibits morphine withdrawal.
    Kotlińska J; Suder P; Legowska A; Rolka K; Silberring J
    Life Sci; 2000 Jan; 66(8):PL119-23. PubMed ID: 10680585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine and inhibition of nitric oxide synthesis produce opioid-mediated antinociception.
    Forman LJ; Tringo L; Sun M
    Brain Res Bull; 1997; 44(2):125-9. PubMed ID: 9292201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Singh I; Singh N; Bansal N; Bansal S; Kumar M
    Eur J Pharmacol; 2008 Nov; 598(1-3):51-6. PubMed ID: 18840427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress.
    Abdel-Zaher AO; Abdel-Rahman MS; Elwasei FM
    Neurotoxicology; 2011 Dec; 32(6):725-33. PubMed ID: 21855572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
    Bhargava HN; Thorat SN
    Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
    Buccafusco JJ; Terry AV; Shuster L
    Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester.
    Adams ML; Kalicki JM; Meyer ER; Cicero TJ
    Life Sci; 1993; 52(22):PL245-9. PubMed ID: 7684108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.